focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,786.00
Bid: 1,785.00
Ask: 1,786.00
Change: -26.50 (-1.46%)
Spread: 1.00 (0.056%)
Open: 1,792.50
High: 1,802.00
Low: 1,785.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amazon and Nestle join public-private plan to save world's forests

Thu, 22nd Apr 2021 15:30

* LEAF coalition aims to raise an initial $1 bln

* Calls for countries to apply by July

* Payouts linked to emissions between 2022-2026

By Simon Jessop

LONDON, April 22 (Reuters) - The United States, Norway and
Britain joined forces with companies including Amazon
and Nestle on Thursday to launch a project aimed at
protecting the world's tropical forests.

Announcing the Lowering Emissions by Accelerating Forest
finance (LEAF) Coalition at the U.S.-convened Leaders Summit on
climate, the public-private project aims to raise at least $1
billion in initial financing, it said.

Governments and companies taking part will pay countries
with tropical and subtropical forests for emissions reductions,
a move it hopes will help reduce and eventually end
deforestation.

As the world looks to move quickly to a low-carbon economy
to prevent catastrophic climate change, protecting the forests
that help remove carbon from the atmosphere naturally is seen as
a crucial step, but one that has so far largely failed.

The pace of deforestation actually picked up in 2020, LEAF
said, with data from Global Forest Watch showing a 12 percent
increase from the prior year or more than 10 million hectares of
primary tropical forest, roughly the size of Switzerland.

"The LEAF coalition is a groundbreaking example of the scale
and type of collaboration that is needed to fight the climate
crisis and achieve net-zero emissions globally by 2050," said
U.S. Special Presidential Envoy for Climate John Kerry.

"Bringing together government and private-sector resources
is a necessary step in supporting the large-scale efforts that
must be mobilized to halt deforestation and begin to restore
tropical and subtropical forests."

Countries looking to take part in the programme will need to
have the reduction in deforestation-linked emissions verified by
a new, more rigorous standard assessed at the national level by
an independent third party, the coalition said in a statement.

With applications due by July 2021 and the aim of signing
contracts before the end of the year, payments would be based on
emissions reductions linked to reducing levels of deforestation
or degradation, or by restoring forests, between 2022 and 2026.

Companies looking to take part in the project will only be
allowed to join if they can show a commitment to "deep voluntary
cuts" in their own emissions, in line with science-based targets
and the Paris Agreement on climate.

"Climate change is the greatest threat to our planet, and
the LEAF coalition offers us an opportunity to bring together
governments and companies to fight it," said Jeff Bezos, Amazon
founder and CEO.

"In uniting behind a common cause, the countries and
companies of the coalition have a chance to end deforestation by
2030."

Among other companies to sign up to the project are Airbnb
, Boston Consulting Group, GlaxoSmithKline,
McKinsey, Salesforce, Bayer and Unilever
, although more are expected to join over time.

U.S. non-profit Emergent will oversee the administration of
the project.
(Reporting by Simon Jessop; Editing by Nick Macfie)

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.